This inventor holds 1 USPTO granted patent. Top assignee: St. Jude Children's Research Hospital. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Innovator in Pharmaceutical Science: Komath V Damoradan
Introduction: Komath V Damoradan, based in Cupertino, California, is a distinguished inventor renowned for contributing significantly to the field of pharmaceutical science. His innovative work focuses on developing compounds that act as carboxylesterase inhibitors, demonstrating the intersection of creativity and scientific inquiry in tackling critical health issues.
Latest Patents: Damoradan holds a pivotal patent titled "Amide, aryl sulfonamide, aryl urea, and α,β-diketone derived carboxylesterase inhibitors, and their methods of use." This patent details a range of amides and derivatives that are valuable as selective inhibitors for both human intestinal carboxylesterase and insect carboxylesterase. The patent emphasizes the applications of these compounds in pharmaceutical compositions and pesticide formulations, highlighting their potential in cancer therapy and managing drug overdoses, thus enhancing the efficacy of insecticides and pesticides.
Career Highlights: Komath V Damoradan currently works at St. Jude Children's Research Hospital, a leading institution dedicated to treating and curing pediatric catastrophic diseases through research and clinical care. His contributions to pharmaceutical innovation are backed by a solid career focused on the development of vital treatments that aim to improve patient outcomes.
Collaborations: Throughout his career, Damoradan has collaborated with notable colleagues, including Philip Michael Potter and Janice Louise Hyatt. These partnerships foster an environment of shared knowledge and expertise, which is essential for advancing research and innovation in the pharmaceutical sector.
Conclusion: Komath V Damoradan exemplifies the spirit of innovation within the pharmaceutical industry. His groundbreaking patent work not only contributes to scientific advancements but also serves as a foundation for future developments in drug therapy and pest management. As he continues to collaborate with other brilliant minds, Damoradan's impact on medical science and public health is sure to expand, showcasing the importance of innovation in addressing global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
